ValuEngine lowered shares of Fresenius Medical Care AG & Co. (NYSE:FMS) from a hold rating to a sell rating in a research note issued to investors on Wednesday, October 17th.
Several other equities analysts also recently commented on the stock. Zacks Investment Research downgraded shares of Fresenius Medical Care AG & Co. from a hold rating to a sell rating in a report on Friday, August 3rd. Royal Bank of Canada reiterated a neutral rating on shares of Fresenius Medical Care AG & Co. in a report on Friday, August 17th. Bank of America started coverage on shares of Fresenius Medical Care AG & Co. in a report on Monday, July 9th. They issued a buy rating on the stock. HSBC upgraded shares of Fresenius Medical Care AG & Co. from a hold rating to a buy rating in a report on Tuesday, August 28th. Finally, DZ Bank reiterated a buy rating on shares of Fresenius Medical Care AG & Co. in a report on Monday, August 6th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and six have issued a buy rating to the company’s stock. The stock currently has an average rating of Hold and a consensus target price of $67.33.
FMS traded down $1.28 during trading on Wednesday, reaching $40.07. 477,012 shares of the stock were exchanged, compared to its average volume of 322,843. The company has a market cap of $26.46 billion, a price-to-earnings ratio of 18.13, a PEG ratio of 1.91 and a beta of 1.10. Fresenius Medical Care AG & Co. has a twelve month low of $38.43 and a twelve month high of $57.94. The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 0.41.
Fresenius Medical Care AG & Co. Company Profile
Fresenius Medical Care AG & Co KGaA provides products and services for patients with chronic kidney failure. The company’s products include dialysis machines, dialyzers and related disposables. It also offers renal information technology solutions and provides services such as renal replacement therapy and therapeutic apheresis.
Further Reading: What is the NASDAQ Stock Market?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Fresenius Medical Care AG & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. and related companies with MarketBeat.com's FREE daily email newsletter.